News Sumitomo Pharma Oncology Receives Orphan Drug Designation for TP-3654, an Investigational Oral Inhibitor of PIM Kinases for the Treatment of Myelofibrosis Jun 15, 2022 Posted by Sumitomo Pharma Oncology, Inc.
News Astrocyte Announces Initiation of First-In-Human Phase 1 Study of the Promising Stroke and Traumatic Brain Injury Therapeutic, AST-004 Jun 15, 2022
News Asymmetrex®’s Kinetic Stem Cell (KSC) Counting Technology Is Featured in the Parent’s Guide to Cord Blood Foundation® June Newsletter Jun 15, 2022
News Batavia Biosciences increases capacity for viral vectors and vaccine R&D in Netherlands. Jun 14, 2022
News Greenberg Traurig’s Melissa Hunter-Ensor Selected as ‘Go To Life Sciences/Healthcare Lawyer’ by Massachusetts Lawyers Weekly Jun 08, 2022 Posted by Greenberg Traurig, LLP
News EVERSANA™ Unveils EVERSANA INTOUCH, a Next-Generation Agency Network Delivering Award-Winning Creative, Digital, and Global Market Access Solutions for Life Sciences Jun 07, 2022 Posted by EVERSANA
News L7 Informatics Raises $38 Million Growth Investment to Digitalize Precision Healthcare Jun 07, 2022
News L7 Informatics Raises $38 Million Growth Investment to Digitalize Precision Healthcare Jun 07, 2022
Whitepapers Five Broad Implications for FDA’s Project Optimus: How to Prepare for the Future of Oncology Trials Jun 02, 2022 Posted by Halloran Consulting Group, Inc.
News EVERSANA and Limitless Minds Advance Pharmaceutical Sales Performance with New Cognitive & Behavioral Training Solution Jun 02, 2022 Posted by EVERSANA
